Home › Funds › PERCEPTIVE ADVISORS LLC › XFOR

PERCEPTIVE ADVISORS LLC position in XFOR

X4 PHARMACEUTICALS INC · Health Care

PERCEPTIVE ADVISORS LLC reported holding 7,933,491 shares of XFOR (X4 PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$37.0M, representing 0.59% of its reported portfolio and ranking #39 among its reported holdings. PERCEPTIVE ADVISORS LLC has disclosed XFOR holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)7.93M sh
Reported value held$37.05M
Portfolio Weight0.59%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PERCEPTIVE ADVISORS LLC's XFOR position evolved

PERCEPTIVE ADVISORS LLC first disclosed a stake in XFOR in Q3 2023 at 3,545,454 shares (US$3.9M). The position peaked in Q2 2026 at 7,933,491 shares, worth US$37.0M. Across 8 filings, PERCEPTIVE ADVISORS LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 7,933,491 shares valued at US$37.0M — an increase of 1,195,843 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.55M $3.86M New
Q4 2023 3.55M $2.97M Hold
Q1 2024 3.55M $4.93M Hold
Q2 2024 3.55M $2.06M Hold
Q3 2024 3.55M $2.37M Hold
Q4 2025 6.31M $25.26M New
Q1 2026 6.74M $27.83M Add
Q2 2026 7.93M $37.05M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XFOR and 13F data

XFOR (X4 PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in XFOR — the largest reported positions include Bain Capital Life Sciences Investors, LLC (US$37.2M), Saturn V Capital Management LP (US$32.6M), Empery Asset Management, LP (US$32.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XFOR

All XFOR fund holders →

FAQ

How long has PERCEPTIVE ADVISORS LLC held XFOR?

PERCEPTIVE ADVISORS LLC has disclosed XFOR holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

What is PERCEPTIVE ADVISORS LLC's current position in XFOR?

As of Q2 2026, PERCEPTIVE ADVISORS LLC holds 7.93M shares of XFOR (X4 PHARMACEUTICALS INC), valued at $37.05M, representing 0.59% of its reported portfolio and ranking #39.

Has PERCEPTIVE ADVISORS LLC been buying or selling XFOR?

In the latest 13F filing (Q2 2026), PERCEPTIVE ADVISORS LLC increased its position in XFOR. The position peaked in Q2 2026 at 7.93M shares.

Which other funds hold XFOR?

Other major institutional holders of XFOR include Bain Capital Life Sciences Investors, LLC, Saturn V Capital Management LP, Empery Asset Management, LP, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.